Coronary microvascular dysfunction and inflammation: Insights from the Coronary Microvascular Disease Registry.
Autor: | Merdler I; Section of Interventional Cardiology, MedStar Washington Hospital Center, Washington, DC, United States of America., Chitturi KR; Section of Interventional Cardiology, MedStar Washington Hospital Center, Washington, DC, United States of America., Chaturvedi A; Section of Interventional Cardiology, MedStar Washington Hospital Center, Washington, DC, United States of America., Li J; Department of Internal Medicine, MedStar Georgetown University Hospital, Washington, DC, United States of America., Cellamare M; Section of Interventional Cardiology, MedStar Washington Hospital Center, Washington, DC, United States of America., Ozturk ST; Section of Interventional Cardiology, MedStar Washington Hospital Center, Washington, DC, United States of America., Sawant V; Section of Interventional Cardiology, MedStar Washington Hospital Center, Washington, DC, United States of America., Ben-Dor I; Section of Interventional Cardiology, MedStar Washington Hospital Center, Washington, DC, United States of America., Waksman R; Section of Interventional Cardiology, MedStar Washington Hospital Center, Washington, DC, United States of America. Electronic address: ron.waksman@medstar.net., Case BC; Section of Interventional Cardiology, MedStar Washington Hospital Center, Washington, DC, United States of America., Hashim HD; Section of Interventional Cardiology, MedStar Washington Hospital Center, Washington, DC, United States of America. |
---|---|
Jazyk: | angličtina |
Zdroj: | Cardiovascular revascularization medicine : including molecular interventions [Cardiovasc Revasc Med] 2024 Dec; Vol. 69, pp. 30-34. Date of Electronic Publication: 2024 May 11. |
DOI: | 10.1016/j.carrev.2024.05.020 |
Abstrakt: | Background: Coronary microvascular dysfunction (CMD) is associated with various inflammatory conditions that worsen endothelial dysfunction. This study aimed to investigate the relationship between CMD and inflammation using common inflammatory markers derived from complete blood count (CBC) analysis. Methods: Information was gathered from the Coronary Microvascular Disease Registry to examine the neutrophil-to-lymphocyte ratio (NLR), eosinophil-to-monocyte ratio (EMR), and monocyte-to-high-density lipoprotein ratio (MHR) in a cohort of patients with angina who showed non-obstructive coronary arteries and underwent invasive physiological assessments for CMD. Results: Of the 171 patients studied, 126 were CMD-negative and 45 were CMD-positive, constituting two groups of interest. The average age of all patients was 61.7 ± 11.1 years, and 63.7 % were female. No significant differences were observed between the two groups in terms of baseline characteristics, cardiovascular risk factors, or potential anti-inflammatory medications. Furthermore, there were no statistically significant differences in NLR (2.54 ± 3.71 vs. 2.52 ± 2.28, p = 0.97), EMR (0.3 ± 0.21 vs. 0.34 ± 0.29, p = 0.31), or MHR (0.02 ± 0.01 vs. 0.01 ± 0.01, p = 0.54) between CMD-positive and CMD-negative patients. Conclusion: Our findings did not show a noteworthy connection between CMD and inflammation, as suggested by various simple CBC-based biomarkers. Competing Interests: Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Kalyan R. Chitturi – Consultant: Glass Health. Brian C. Case – Speaker: Asahi Intecc USA, Zoll Medical. Ron Waksman – Advisory Board: Abbott Vascular, Boston Scientific, Medtronic, Philips IGT, Pi-Cardia Ltd.; Consultant: Abbott Vascular, Append Medical, Biotronik, Boston Scientific, JC Medical, MedAlliance/Cordis, Medtronic, Philips IGT, Pi-Cardia Ltd., Swiss Interventional/SIS Medical AG, Transmural Systems Inc.; Institutional Grant Support: Biotronik, Medtronic, Philips IGT; Investor: Append Medical, Pi-Cardia Ltd., Transmural Systems Inc. Hayder D. Hashim – Advisory Board, Speaker: Abbott Vascular, Boston Scientific, Philips IGT. All other authors – None. (Copyright © 2024. Published by Elsevier Inc.) |
Databáze: | MEDLINE |
Externí odkaz: |